Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPHYSOME: AmBisome Weekly Prophylaxis
NCT00362544Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal amphotericin b in invasive fungal infection (IFI), sponsored by Gilead Sciences. Started Oct 2003; status: completed.
02
Drugs
liposomal amphotericin b
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00362544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362544.